Fetoplacental regional variations in the expression of angiopoietin-1, angiopoietin-2, and Tie2 in normal-term and near-term pregnancies

References

• Di Renzo GC. The role of an ‘anti-angiogenic state’ in complications of pregnancy. J Matern Fetal Neonatal Med 2008;21:3–7
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649–58
   PubMed Web of Science ®Google Scholar
• Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008;21:9–23
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Whitten AE, et al. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia. J Matern Fetal Neonatal Med 2015;14:1–15
   Google Scholar
• Stampalija T, Chaiworapongsa T, Romero R, et al. Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia. J Matern Fetal Neonatal Med 2013;26:1359–70
   PubMed Web of Science ®Google Scholar
• Whitten AE, Romero R, Korzeniewski SJ, et al. Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death. Am J Obstet Gynecol 2013;208:310.e1–1
   Web of Science ®Google Scholar
• Maulik D, De A, Ragolia L, et al. Down-regulation of placental neuropilin-1 in fetal growth restriction. Am J Obstet Gynecol 2016;214:279.e1–9
   Web of Science ®Google Scholar
• Fukuhara S, Sako K, Noda K, et al. Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histol Histopathol 2010;25:387–96
   PubMed Web of Science ®Google Scholar
• Augustin HG, Koh GY, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 2009;10:165–77
   PubMed Web of Science ®Google Scholar
• Dunk C, Shams M, Nijjar S, et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie2 to promote growth and migration during placental development. Am J Pathol 2000;156:2185–99
   PubMed Web of Science ®Google Scholar
• Goldman-Wohl DS, Ariel I, Greenfield C, et al. Tie2 and angiopoietin-2 expression at the fetal-maternal interface: a receptor ligand model for vascular remodelling. Mol Hum Reprod 2000;6:81–7
   PubMed Web of Science ®Google Scholar
• Zhang EG, Smith SK, Baker PN, Charnock-Jones DS. The regulation and localization of angiopoietin-1, -2, and their receptor Tie2 in normal and pathologic human placentae. Mol Med 2001;7:624–35
   PubMed Web of Science ®Google Scholar
• Geva E, Ginzinger DG, Zaloudek CJ, et al. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 2002;87:4213–24
   PubMed Web of Science ®Google Scholar
• Tseng JJ, Hsu SL, Ho ES, et al. Differential expression of angiopoietin-1, angiopoietin-2, and Tie receptors in placentas from pregnancies complicated by placenta accreta. Am J Obstet Gynecol 2006;194:564–71
   PubMed Web of Science ®Google Scholar
• Fox H. The pattern of villous variability in the normal placenta. J Obstet Gynaecol Br Commonw 1964;71:749–58
   PubMedGoogle Scholar
• Wyatt SM, Kraus FT, Roh CR, et al. The correlation between sampling site and gene expression in the term human placenta. Placenta 2005;26:372–9
   PubMed Web of Science ®Google Scholar
• Pidoux G, Gerbaud P, Laurendeau I, et al. Large variability of trophoblast gene expression within and between human normal term placentae. Placenta 2004;25:469–73
   PubMed Web of Science ®Google Scholar
• Tzschoppe AA, Struwe E, Dörr HG, et al. Differences in gene expression dependent on sampling site in placental tissue of fetuses with intrauterine growth restriction. Placenta 2010;31:178–85
   PubMed Web of Science ®Google Scholar
• American Congress of Obstetricians and Gynecologists (ACOG) Practice Bulletin; No. 101: Ultrasonography in Pregnancy. Washington (DC); 2005
   Google Scholar
• Cindrova-Davies T, Yung HW, Johns J, et al. Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. Am J Pathol 2007;171:1168–79
   PubMed Web of Science ®Google Scholar
• Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003;3:6
   PubMedGoogle Scholar
• Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577–80
   PubMed Web of Science ®Google Scholar
• Burton GJ, Charnock-Jones DS, Jauniaux E. Regulation of vascular growth and function in the human placenta. Reproduction 2009;138:895–902
   PubMed Web of Science ®Google Scholar
• Yuan HT, Khankin EV, Karumanchi SA, Parikh SM. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol 2009;29:2011–22
   PubMed Web of Science ®Google Scholar
• Silver KL, Zhong K, Leke RG, et al. McLaughlin–Rotman dysregulation of angiopoietins is associated with placental malaria and low birth weight. PLoS One 2010;5:e9481
   PubMed Web of Science ®Google Scholar
• Raijmakers MT, Bruggeman SW, Steegers EA, Peters WH. Distribution of components of the glutathione detoxification system across the human placenta after uncomplicated vaginal deliveries. Placenta 2002;23:490--6
   PubMed Web of Science ®Google Scholar